Study: Male Contraceptive Prevents Pregnancy in Monkeys

Researchers injected a non-hormonal hydrogel contraceptive into 16 male rhesus monkeys, finding that it prevented pregnancy for an entire breeding season.

Written byJoshua A. Krisch
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, JINTERWASThe search for a male contraceptive has led to competitions for better birth control and multimillion dollar investments from Silicon Valley. Now a February 7 study in Basic and Clinical Andrology has shown that Vasalgel, a hydrogel that can be injected into the vas deferens to block sperm, appears to have prevented pregnancy in rhesus monkeys with fewer side effects than a vasectomy.

“Vasectomies are a routine procedure for nonhuman primate veterinarians, so to have similar or even slightly better outcomes trying a brand-new procedure is very encouraging,” coauthor Angela Colagross-Schouten, a veterinarian at the University of California, Davis’s California National Primate Research Center, said in a statement. “Hopefully, Vasalgel placement can be an option for other captive colonies, including zoos, that want to manage reproductive rates while allowing for social housing.”

Vasalgel is a polymer that can be injected into the vas deferens to form a spongy, high molecular–weight hydrogel that allows important bodily fluids, including semen—but not sperm cells—to pass through. In a forthcoming study involving rabbits, Colagross-Schouten said she and her colleagues have demonstrated that the process can be reversed by flushing the hydrogel out ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies